239 related articles for article (PubMed ID: 23354296)
1. Systematic comparison of four cell- and Luminex-based methods for assessment of complement-activating HLA antibodies.
Lachmann N; Todorova K; Schulze H; Schönemann C
Transplantation; 2013 Mar; 95(5):694-700. PubMed ID: 23354296
[TBL] [Abstract][Full Text] [Related]
2. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
[TBL] [Abstract][Full Text] [Related]
3. C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.
Llorente S; Boix F; Eguia J; López M; Bosch A; Martinez H; Gonzalez MJ; López-Hernández R; Salgado G; Moya-Quiles MR; Campillo JA; García-Alonso AM; Minguela A; Jimeno L; Alvarez-López MR; Muro M
Transplant Proc; 2012 Nov; 44(9):2535-7. PubMed ID: 23146446
[TBL] [Abstract][Full Text] [Related]
4. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
[TBL] [Abstract][Full Text] [Related]
5. Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays.
Visentin J; Vigata M; Daburon S; Contin-Bordes C; Fremeaux-Bacchi V; Dromer C; Billes MA; Neau-Cransac M; Guidicelli G; Taupin JL
Transplantation; 2014 Sep; 98(6):625-31. PubMed ID: 25058376
[TBL] [Abstract][Full Text] [Related]
6. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.
Chen G; Sequeira F; Tyan DB
Hum Immunol; 2011 Oct; 72(10):849-58. PubMed ID: 21791230
[TBL] [Abstract][Full Text] [Related]
7. Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry.
AlMahri A; Holgersson J; Alheim M
Tissue Antigens; 2012 Nov; 80(5):404-15. PubMed ID: 22931381
[TBL] [Abstract][Full Text] [Related]
8. Comparison Between Total IgG, C1q, and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies.
Moreno Gonzales MA; Mitema DG; Smith BH; Schinstock CA; Stegall MD; Wakefield LL; Henderson NA; DeGoey SR; Kreuter JD; Gandhi MJ
Transplant Proc; 2017 Nov; 49(9):2031-2035. PubMed ID: 29149956
[TBL] [Abstract][Full Text] [Related]
9. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients.
Wahrmann M; Bartel G; Exner M; Regele H; Körmöczi GF; Fischer GF; Böhmig GA
Transpl Int; 2009 Oct; 22(10):982-9. PubMed ID: 19619171
[TBL] [Abstract][Full Text] [Related]
11. C1q assay for the detection of complement fixing antibody to HLA antigens.
Chen G; Tyan DB
Methods Mol Biol; 2013; 1034():305-11. PubMed ID: 23775744
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
Rose ML; Smith JD
Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
[TBL] [Abstract][Full Text] [Related]
13. C4d binding correlated with strong HLA antibodies involved in graft failures.
Mizutani K; Gotoh M
Transplant Proc; 2010 Dec; 42(10):4021-5. PubMed ID: 21168616
[TBL] [Abstract][Full Text] [Related]
14. Modified solid-phase alloantibody detection for improved crossmatch prediction.
Wahrmann M; Hlavin G; Fischer G; Marinova L; Schwaiger E; Hörl WH; Zlabinger GJ; Körmöczi GF; König F; Böhmig GA
Hum Immunol; 2013 Jan; 74(1):32-40. PubMed ID: 23073293
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Circulating Complement-Fixing Donor-Specific Antibodies Identified by the C1q Assay and Presence of C4d in Endomyocardial Biopsy Specimens.
Frank R; Lal P; Kearns J; Molina MR; Wald JW; Goldberg LR; Kamoun M
Am J Clin Pathol; 2016 Jan; 145(1):62-8. PubMed ID: 26712872
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Complement-Binding Capacity of HLA Antibodies Based on Mean Fluorescence Intensity.
Zhao J; Fu YX; Yang T; Shen ZY; Wu CL
Transplant Proc; 2016; 48(6):2235-40. PubMed ID: 27569975
[TBL] [Abstract][Full Text] [Related]
17. Post-transplant development of C1q-positive HLA antibodies and kidney graft survival.
Piazza A; Poggi E; Ozzella G; Adorno D
Clin Transpl; 2013; ():367-75. PubMed ID: 25095531
[TBL] [Abstract][Full Text] [Related]
18. Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.
Fontaine MJ; Kuo J; Chen G; Galel SA; Miller E; Sequeira F; Viele M; Goodnough LT; Tyan DB
Transfusion; 2011 Dec; 51(12):2611-8. PubMed ID: 21615749
[TBL] [Abstract][Full Text] [Related]
19. C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation.
Smith JD; Hamour IM; Banner NR; Rose ML
Am J Transplant; 2007 Dec; 7(12):2809-15. PubMed ID: 17908268
[TBL] [Abstract][Full Text] [Related]
20. Assignment of C1q-binding HLA antibodies as unacceptable HLA antigens avoids positive CDC-crossmatches prior to transplantation of deceased donor organs.
Juhl D; Marget M; Hallensleben M; Görg S; Ziemann M
Transpl Immunol; 2017 Mar; 41():17-21. PubMed ID: 28088367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]